Journal of Biological Chemistry · 2004 · 113 citations · 19 references
Life SciencesBiochemistryCell BiologyApoptosisCellular BiochemistryMitochondrial BiologyApoptotic SignalingCaspase ActivationCytochrome C ReleaseMitochondrial MembranesMitochondrial Outer Membrane PermeabilizationMitochondrial Stress ResponsesCysteine ProteasesCytochrome C BindingCytochrome C-mediated Caspase ActivationDiablo ReleaseMitochondrial Apoptosis PathwaysMitochondrial Membrane PermeabilizationMitochondrial Pathway Of ApoptosisSmac Release
Caspases are cysteine proteases that play a central role in the execution of apoptosis. Recent evidence indicates that caspase-2 is activated early in response to genotoxic stress and can function as an upstream modulator of the mitochondrial apoptotic pathway. In particular, we have shown previously that fully processed caspase-2 can permeabilize the outer mitochondrial membrane and cause cytochrome c and Smac/DIABLO release from these organelles. Using permeabilized cells, isolated mitochondria, and protein-free liposomes, we now report that this effect is direct and depends neither on the presence or cleavage of other proteins nor on a specific phospholipid composition of the liposomal membrane. Interestingly, caspase-2 was also shown to disrupt the interaction of cytochrome c with anionic phospholipids, notably cardiolipin, and thereby enhance the release of the hemoprotein caused by treatment of mitochondria with digitonin or the proapoptotic protein Bax. Combined, our data suggest that caspase-2 possesses an unparalleled ability to engage the mitochondrial apoptotic pathway by permeabilizing the outer mitochondrial membrane and/or by breaching the association of cytochrome c with the inner mitochondrial membrane. Caspases are cysteine proteases that play a central role in the execution of apoptosis. Recent evidence indicates that caspase-2 is activated early in response to genotoxic stress and can function as an upstream modulator of the mitochondrial apoptotic pathway. In particular, we have shown previously that fully processed caspase-2 can permeabilize the outer mitochondrial membrane and cause cytochrome c and Smac/DIABLO release from these organelles. Using permeabilized cells, isolated mitochondria, and protein-free liposomes, we now report that this effect is direct and depends neither on the presence or cleavage of other proteins nor on a specific phospholipid composition of the liposomal membrane. Interestingly, caspase-2 was also shown to disrupt the interaction of cytochrome c with anionic phospholipids, notably cardiolipin, and thereby enhance the release of the hemoprotein caused by treatment of mitochondria with digitonin or the proapoptotic protein Bax. Combined, our data suggest that caspase-2 possesses an unparalleled ability to engage the mitochondrial apoptotic pathway by permeabilizing the outer mitochondrial membrane and/or by breaching the association of cytochrome c with the inner mitochondrial membrane. Apoptosis is executed by a family of cysteine proteases known as caspases. In vertebrates, these enzymes are present constitutively as zymogens and become activated in response to numerous apoptotic stimuli (1Shi Y. Cell. 2004; 117: 855-858Abstract Full Text Full Text PDF PubMed Scopus (280) Google Scholar). Once activated, caspases cleave proteins after aspartate residues and thereby bring about many of the biochemical and morphological features characteristic of apoptosis. Of the two primary caspase activation pathways (death receptor-mediated and mitochondrially mediated), the mitochondrial pathway is most commonly associated with apoptosis triggered by cytotoxic stress and involves the activation of caspase-9 within the Apaf-1-containing apoptosome complex (2Danial N.N. Korsmeyer S.J. Cell. 2004; 116: 205-219Abstract Full Text Full Text PDF PubMed Scopus (4060) Google Scholar). Until recently, the dominant viewpoint has been that caspase-9 activation represents the apex of the caspase cascade during stress-induced apoptosis. However, this hypothesis is currently being challenged by evidence suggesting that caspase-2 may be critical for the engagement of the mitochondrial pathway, and hence caspase-9 activation, during DNA damage-induced apoptosis (3Robertson J.D. Gogvadze V. Zhivotovsky B. Orrenius S. J. Biol. Chem. 2000; 275: 32438-32443Abstract Full Text Full Text PDF PubMed Scopus (140) Google Scholar, 4Robertson J.D. Enoksson M. Suomela M. Zhivotovsky B. Orrenius S. J. Biol. Chem. 2002; 277: 29803-29809Abstract Full Text Full Text PDF PubMed Scopus (360) Google Scholar, 5Lassus P. Opitz-Araya X. Lazebnik Y. Science. 2002; 297: 1352-1354Crossref PubMed Scopus (660) Google Scholar). Although it was the first mammalian apoptotic caspase to be identified (6Kumar S. Kinoshita M. Noda M. Copeland N.G. Jenkins N.A. Genes Dev. 1994; 8: 1613-1626Crossref PubMed Scopus (588) Google Scholar, 7Wang L. Miura M. Bergeron L. Zhu H. Yuan J. Cell. 1994; 78: 739-750Abstract Full Text PDF PubMed Scopus (801) Google Scholar) and is the evolutionarily best conserved member of this family (8Lamkanfi M. Declercq W. Kalai M. Saelens X. Vandenabeele P. Cell Death Differ. 2002; 9: 358-361Crossref PubMed Scopus (305) Google Scholar), the role of caspase-2 in apoptotic cell death remains contentious. Like caspase-9 it contains a caspase recruitment domain (CARD), but recent evidence indicates that caspase-2 activation occurs in an Apaf-1-independent complex, which also includes the death domain (DD)-containing protein PIDD and the adaptor protein RAIDD (9Read S.H. Baliga B.C. Ekert P.G. Vaux D.L. Kumar S. J. Cell Biol. 2002; 159: 739-745Crossref PubMed Scopus (146) Google Scholar, 10Tinel A. Tschopp J. Science. 2004; 304: 843-846Crossref PubMed Scopus (546) Google Scholar). Additional findings have shown that caspase-2 retains a unique ability to engage directly the mitochondrial apoptotic pathway (4Robertson J.D. Enoksson M. Suomela M. Zhivotovsky B. Orrenius S. J. Biol. Chem. 2002; 277: 29803-29809Abstract Full Text Full Text PDF PubMed Scopus (360) Google Scholar, 11Guo Y. Srinivasula S.M. Druilhe A. Fernandes-Alnemri T. Alnemri E.S. J. Biol. Chem. 2002; 277: 13430-13437Abstract Full Text Full Text PDF PubMed Scopus (450) Google Scholar), an effect that appears to require processing of the zymogen but not the associated catalytic activity (12Robertson J.D. Gogvadze V. Kropotov A. Vakifahmetoglu H. Zhivotovsky B. Orrenius S. EMBO Rep. 2004; 5: 643-648Crossref PubMed Scopus (117) Google Scholar). The aim of the current study was to determine more precisely the molecular requirements for caspase-2-mediated engagement of the mitochondrial apoptotic pathway. The results indicate that processed recombinant human caspase-2 triggers a rapid and concentration-dependent release of cytochrome c from isolated mitochondria as well as liposomes. This occurs independently of other proteins and does not require a specific phospholipid profile within liposomes. In addition, our results demonstrate that caspase-2 has the capacity to detach cytochrome c from the inner mitochondrial membrane by compromising its association with anionic phospholipids. Expression and Purification of Caspase-2 Proteins—Bacterial expression plasmids containing active, catalytically inactive (C303A) (11Guo Y. Srinivasula S.M. Druilhe A. Fernandes-Alnemri T. Alnemri E.S. J. Biol. Chem. 2002; 277: 13430-13437Abstract Full Text Full Text PDF PubMed Scopus (450) Google Scholar), or uncleavable (D316G) recombinant caspase-2 were expressed in Escherichia coli strain BL21(DE3) as C- or N-terminal His6-tagged proteins using pET-21a or pET-28a vector (Novagen) and purified by standard Ni2+-affinity chromatography. Site-directed Mutagenesis—Active caspase-2 was used as a template to introduce a D316G point mutation using the QuikChange II site-directed mutagenesis kit (Stratagene, La Jolla, CA). The mutation was confirmed by sequence analysis. Cell Culture—Jurkat T-lymphocytes were cultured in RPMI 1640 complete medium supplemented with 10% (v/v) heat-inactivated fetal bovine serum, 2% (w/v) glutamine, 100 units/ml penicillin, and 100 μg/ml streptomycin in a humidified air/CO2 (19:1) atmosphere at 37 °C. Cells were maintained in a logarithmic growth phase for all experiments. Digitonin-permeabilized Cells—Jurkat T-lymphocytes (106) were washed in phosphate-buffered saline and resuspended in 100 μl KCl-sucrose buffer (140 mm mannitol, 46 mm sucrose, 50 mm KCl, 1 mm KH2PO4, 5 mm succinate, 1 mm EGTA, 5 mm Tris, pH 7.4). Following a 2-min stabilization period, cells were permeabilized with 5 μg of digitonin, and 5 μm rotenone was added to maintain pyridine nucleotides in a reduced form. Isolation of Rat Liver Mitochondria—The liver of a male Sprague-Dawley rat was minced on ice, resuspended in 50 ml of MSH buffer (210 mm mannitol, 70 mm sucrose, 5 mm Hepes, pH 7.5) supplemented with 1 mm EDTA, and homogenized with a tight-fitting glass-Teflon motorized homogenizer. Homogenates were centrifuged at 600 × g for 8 min at 4 °C. The supernatant was decanted and centrifuged at 5,500 × g for 15 min to form a mitochondrial pellet that was washed in MSH buffer, re-centrifuged at 5,500 × g for 15 min, and resuspended in MSH buffer at a protein concentration of 80–100 mg/ml. Caspase-2-induced Cytochrome c Release—Isolated rat liver mitochondria (1 mg/ml) were incubated in the presence or absence of recombinant caspase-2 in a final volume of 100 μl. Incubations were performed either in buffer A, consisting of 140 mm mannitol, 46 mm sucrose, 50 mm KCl, 1 mm KH2PO4, 5 mm succinate, 1 mm EGTA, pH 7.4, or buffer B (where indicated), consisting of 150 mm KCl, 1 mm KH2PO4, 5 mm succinate, 1 mm EGTA, 5 mm Tris, pH 7.4. For caspase-2-induced cytochrome c release from Jurkat T-lymphocytes, cells (106) were washed in phosphate-buffered saline, resuspended in 100 μl buffer A, and permeabilized with digitonin (5 μg). Following a 1-min stabilization period, the indicated amount of recombinant caspase-2 was added. Preparation of Liposomes—Lyophilized dioleoyl phosphatidylcholine (PC), 1The abbreviations used are: PC, phosphatidylcholine; PI, phosphatidylinositol; CL, cardiolipin; FITC, fluorescein isothiocyanate; CCCP, m-chlorophenylhydrazone; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid. phosphatidylinositol (PI), and bovine heart cardiolipin (CL) (all from Sigma) were resuspended in chloroform to concentrations of 10–50 mg/ml. Sucrose-loaded liposomes consisting of PC (80%) and PI (20%), PC (80%), and CL (20%) or PC (100%) were prepared using published protocols (13Buser C.A. McLaughlin S. Methods Mol. Biol. 1998; 84: 267-281PubMed Google Scholar). Briefly, liposomes of uniform size were prepared in sucrose buffer (256 mm sucrose, 5 mm Tris, pH 7.4) using a lipid extruder equipped with 0.1-μm pore-sized polycarbonate filter (Avanti Polar Lipids, Alabaster, AL). Liposomes prepared for pore-forming experiments were made in sucrose buffer supplemented with 5 mg/ml 20-kDa dextran-fluorescein isothiocyanate (FITC) (Sigma) or 50–200 μg/ml bovine heart cytochrome c (Sigma). After five washes in KCl buffer, the liposome pellets were resuspended in sucrose buffer and stored for a maximum of 1 week at 4 °C. Dextran-FITC liposomes were used within 24 h. Caspase-2-induced Release from Liposomes—Liposomes (100 μg/ml) filled with cytochrome c or 20-kDa dextran-FITC were incubated with various amounts of caspase-2, mutant caspase-2, or caspase-3 in KCl buffer for 20 min at 22 °C. After centrifugation at 100,000 × g for 45 min, the amount of cytochrome c or dextran-FITC in the supernatant and pellet was evaluated. Cytochrome c release was monitored by Western blotting, whereas dextran release was monitored in duplicates of 150 μl/well in a 96-well plate by recording the FITC fluorescence in a Fluoroscan II plate reader (Labsystems, Stockholm, Sweden) using an excitation wavelength of 485 nm and monitoring wavelength of 538 nm. KCl buffer was used as a blank. The extent of dextran-FITC release is reported as a percentage of the total after complete lysis of the liposome pellet with 1% CHAPS in KCl buffer. Cytochrome c Binding to Sucrose-loaded Liposomes—Bovine heart cytochrome c (250 μg/ml final concentration) was incubated with sucrose-loaded liposomes (100 μg/ml) for 30 min at 22 °C in KCl buffer. The liposomes were washed three times in KCl buffer to diminish nonspecific binding of cytochrome c to the phospholipids. Caspase-2 or mutant caspase-2 was added at the indicated concentrations, incubated for 20 min, and the supernatant was subsequently separated from the pellet by centrifugation at 100,000 × g for 45 min. Cytochrome c binding and release were detected by Western blotting. Western Blot Analysis—Western blot analysis was carried out as described previously (4Robertson J.D. Enoksson M. Suomela M. Zhivotovsky B. Orrenius S. J. Biol. Chem. 2002; 277: 29803-29809Abstract Full Text Full Text PDF PubMed Scopus (360) Google Scholar). The antibody used was anti-cytochrome c (1:2,500) (Pharmingen). Estimation of Mitochondrial Respiration—Oxygen consumption by isolated rat liver mitochondria was measured using a Clark-type oxygen electrode (Yellow Spring Instrument Co.) at 25 °C. Mitochondria with a respiratory control ratio (defined as the rate of respiration in the presence of ADP divided by the rate obtained following the expenditure of ADP) above 4 were used for all experiments. Fresh mitochondria were prepared for each experiment and used within 4 h. Caspase-2 Induces a Rapid and Concentration-dependent Release of Cytochrome c—We have shown recently that caspase-2 can trigger the release of cytochrome c and Smac/DIABLO from isolated liver mitochondria as well as permeabilized Jurkat T-lymphocytes (12Robertson J.D. Gogvadze V. Kropotov A. Vakifahmetoglu H. Zhivotovsky B. Orrenius S. EMBO Rep. 2004; 5: 643-648Crossref PubMed Scopus (117) Google Scholar). This effect appears to require processing of the zymogen but not the associated catalytic activity. To further examine the ability of caspase-2 to permeabilize mitochondria and stimulate cytochrome c release, we used wild-type (C-2), catalytically inactive (C303A), and uncleavable (D316G) recombinant caspase-2 proteins to treat permeabilized Jurkat cells, isolated liver mitochondria, or liposomes that had been loaded with either FITC-coupled 20-kDa dextran or bovine heart cytochrome c. Importantly, catalytically inactive caspase-2 (C303A) possessed no VDVADase activity (12Robertson J.D. Gogvadze V. Kropotov A. Vakifahmetoglu H. Zhivotovsky B. Orrenius S. EMBO Rep. 2004; 5: 643-648Crossref PubMed Scopus (117) Google Scholar), whereas uncleavable caspase-2 (D316G) retained ∼20% activity relative to that of wild type, which is consistent with data reported previously (14Baliga B.C. Kumar S. Cell Death Differ. 2004; (doi10.1038/sj.cdd.4401492)PubMed Google Scholar). When recombinant wild-type caspase-2 was added to permeabilized Jurkat cells (Fig. 1A) or isolated liver mitochondria (Fig. 1B), cytochrome c was released in a rapid and concentration-dependent manner. In contrast, neither catalytically inactive nor uncleavable caspase-2 was able to induce any cytochrome c release (Fig. 1C). Furthermore, only wild-type caspase-2 caused a significant decline in the rate of uncoupled respiration (VCCCP) when mitochondria were incubated with m-chlorophenylhydrazone (CCCP) (Fig. 1D), an effect that was most likely due to the prominence of cytochrome c release in the presence of caspase-2 (Fig. 1C). These findings, combined with our earlier results demonstrating that the proteolytic activity of caspase-2 is dispensable for membrane permeabilization and/or the release of cytochrome c, suggested that fully processed caspase-2 was targeting directly the outer mitochondrial membrane, or contact sites between the inner and outer mitochondrial membranes, to cause the release of proapoptotic proteins. Caspase-2 Causes Membrane Permeabilization of Dextran- or Cytochrome c-containing Liposomes—To test this premise and to determine more precisely the molecular requirements for caspase-2-induced membrane permeabilization, experiments were performed using dextran-containing, protein-free liposomes. Importantly, liposome-based methodology has been used by several groups to faithfully mimic the behavior of mitochondria (15Kuwana T. Mackey M.R. Perkins G. Ellisman M.H. Latterich M. Schneiter R. Green D.R. Newmeyer D.D. Cell. 2002; 111: 331-342Abstract Full Text Full Text PDF PubMed Scopus (1237) Google Scholar, 16Epand R.F. Martinou J.C. Montessuit S. Epand R.M. Biochem. J. 2002; 367: 849-855Crossref PubMed Scopus (38) Google Scholar). Here, liposomes of varying composition (100% PC; 20% PI, 80% PC; and 20% CL, 80% PC) containing FITC-coupled 20-kDa dextran were prepared and incubated with different amounts of recombinant caspase-2. As illustrated in Fig. 2A, recombinant caspase-2 induced a similar concentration-dependent release of dextran from all three liposome preparations, whereas caspase-3 and the two caspase-2 mutant proteins stimulated the release of only trace amounts of dextran. In light of these findings, the next step was to determine whether caspase-2 would trigger a similar release of cytochrome c from liposomes. However, because cytochrome c preferentially binds to anionic phospholipids, notably CL located in the inner mitochondrial membrane (17Tuominen E.K. Wallace C.J. Kinnunen P.K. J. Biol. Chem. 2002; 277: 8822-8826Abstract Full Text Full Text PDF PubMed Scopus (267) Google Scholar, 18Iverson S.L. Enoksson M. Gogvadze V. Ott M. Orrenius S. J. Biol. Chem. 2004; 279: 1100-1107Abstract Full Text Full Text PDF PubMed Scopus (71) Google Scholar), we conjectured that the binding of cytochrome c to CL-containing liposomes might be different. Therefore, to ensure equal loading and binding to the lipid membrane among all liposome preparations, different amounts of cytochrome c were used for liposomes containing an anionic phospholipid (PI or CL) as compared with liposomes containing only PC (50 μg of cytochrome c/ml and 200 μg of cytochrome c/ml, respectively). Treatment of liposomes with caspase-2 resulted in the same release pattern of cytochrome c as was observed for the dextran experiments. Specifically, amounts of caspase-2 to only trace amounts of cytochrome c release, whereas cytochrome c release was observed when liposomes were incubated with either or of caspase-2 (Fig. neither caspase-3 nor mutant caspase-2 was able to induce a release of cytochrome c from the liposomes (Fig. which is consistent with our findings with isolated mitochondria and permeabilized cells (12Robertson J.D. Gogvadze V. Kropotov A. Vakifahmetoglu H. Zhivotovsky B. Orrenius S. EMBO Rep. 2004; 5: 643-648Crossref PubMed Scopus (117) Google Scholar). Caspase-2 Causes of Cytochrome c from the of we during the experiments (Fig. that liposomes with cytochrome c to the outer well as the of the membrane, as a of would release cytochrome c when incubated in the presence of concentrations of caspase-2 not As this was in liposomes containing CL and be by caspase-2-mediated of cytochrome c from CL on the outer of liposomes. To further this experiments were performed with sucrose-loaded liposomes that had cytochrome c to the outer only (Fig. These liposomes were incubated with cytochrome c (250 μg/ml) and washed with KCl buffer. This had the effect of the amount of cytochrome c to the outer of cytochrome c binding to the anionic phospholipids, PI and CL (Fig. and concentrations of caspase-2 that were for permeabilization Fig. and were used to treat these liposomes (Fig. The results indicated that caspase-2 caused the of cytochrome c from liposomes containing either PI or CL (Fig. and caspase-2 was more at cytochrome c from the outer of CL-containing liposomes (Fig. suggesting that caspase-2 may have a for cardiolipin as has been described previously for M. M. X. M. X. X. Cell Biol. 2000; PubMed Scopus Google Scholar, Y. X. J. H. Mol. Biol. Cell. 2004; PubMed Scopus Google Scholar). of Caspase-2 Cytochrome c Release by or caspase-2 to be cytochrome c binding to CL in liposomes, it was of to test this using To that isolated rat liver mitochondria were incubated with a amount of caspase-2 and either recombinant or digitonin (Fig. and In the of of caspase-2 to more cytochrome c being due to caspase-2-mediated of the interaction between cytochrome c and Importantly, the cytochrome c release data with the data obtained of caspase-2 had no effect on its with digitonin resulted in a more decline in and uncoupled (CCCP) respiration was observed with digitonin (Fig. The rate of uncoupled respiration was of cytochrome c in the the current we that caspase-2 can permeabilize the outer mitochondrial membrane in a direct manner. with liposomes that this neither other proteins nor a phospholipid composition of the liposomal membrane. Permeabilization appears to have been due to as of liposomes with caspase-2 not in any in size not combined with our that was not released by treatment of isolated mitochondria or permeabilized Jurkat cells with caspase-2, whereas cytochrome c and Smac/DIABLO a effect of caspase-2 being for the release of proteins from mitochondria (12Robertson J.D. Gogvadze V. Kropotov A. Vakifahmetoglu H. Zhivotovsky B. Orrenius S. EMBO Rep. 2004; 5: 643-648Crossref PubMed Scopus (117) Google Scholar). Binding of cytochrome c to the inner mitochondrial membrane is known to a unique mitochondrial cardiolipin (17Tuominen E.K. Wallace C.J. Kinnunen P.K. J. Biol. Chem. 2002; 277: 8822-8826Abstract Full Text Full Text PDF PubMed Scopus (267) Google Scholar). is also evidence that a of cardiolipin in the mitochondrial membrane, as a of or to cytochrome c binding and the of cells to mitochondrially apoptosis S.L. Orrenius S. Biochem. 2004; PubMed Scopus Google Scholar) for Furthermore, cardiolipin was shown to be a mitochondrial for the proapoptotic and to play a critical role in mitochondrial c release by (15Kuwana T. Mackey M.R. Perkins G. Ellisman M.H. Latterich M. Schneiter R. Green D.R. Newmeyer D.D. Cell. 2002; 111: 331-342Abstract Full Text Full Text PDF PubMed Scopus (1237) Google Scholar, M. M. X. M. X. X. Cell Biol. 2000; PubMed Scopus Google Scholar, Y. X. J. H. Mol. Biol. Cell. 2004; PubMed Scopus Google Scholar, B. H. J. R.M. A. G. J. Biol. Chem. 2004; 279: Full Text Full Text PDF PubMed Scopus Google Scholar). The cardiolipin and other anionic can for cardiolipin, but association with cytochrome c is as compared with that of cardiolipin S.L. Enoksson M. Gogvadze V. Ott M. Orrenius S. J. Biol. Chem. 2004; 279: 1100-1107Abstract Full Text Full Text PDF PubMed Scopus (71) Google Scholar). results that caspase-2 has the ability to disrupt the association between cytochrome c and anionic phospholipids, notably CL, thereby cytochrome c for release the This effect more cytochrome c is released from mitochondria with caspase-2 as compared with digitonin or recombinant Bax. might be that caspase-2 can stimulate of mitochondrial in a that of Y. X. J. H. Mol. Biol. Cell. 2004; PubMed Scopus Google Scholar). the of pathways cytotoxic stress with mitochondrial engagement B. G. Mol. Cell. Biol. 2004; 5: PubMed Scopus Google for it would that the extent of the of caspase-2 is likely to on a of the of the cytotoxic the cell that is being and the of caspase-2 relative to that of other proapoptotic proteins current data suggest that in caspase-2 may be for direct permeabilization of the outer mitochondrial membrane, in other caspase-2 may in with to cytochrome c release by its from However, are to these different play out Alnemri for the caspase-2 and caspase-2 expression and for
19
Bid, Bax, and Lipids Cooperate to Form Supramolecular Openings in the Outer Mitochondrial Membrane
Tomomi Kuwana, Mason Mackey, Guy Perkins et al. · Cell · 2002 · 1.5K citations · Full text
Sharad Kumar, M. Kinoshita, Makoto Noda et al. · Genes & Development · 1994 · 595 citations · Full text